Skip to content
10-K

Annual Report

PALISADE BIO, INC. PALI

0001357459-26-000004

← back to feed
Filed
Mar 20, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 18, 2026 165.88M sh
Shares Diluted FY 2025 · Dec 31, 2025 55.67M sh
Shares Diluted FY 2025 · Dec 31, 2024 1.42M sh
Operating Cash Flow FY 2025 · Dec 31, 2025 −$10.85M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$12.19M
Cash And Equivalents FY 2025 · Dec 31, 2025 $133.39M
Cash And Equivalents FY 2025 · Dec 31, 2024 $9.82M
Stockholders Equity FY 2025 · Dec 31, 2025 $129.38M
Stockholders Equity FY 2025 · Dec 31, 2024 $7.49M
Stockholders Equity FY 2025 · Dec 31, 2023 $11.31M
Current Liabilities FY 2025 · Dec 31, 2025 $4.64M
Current Liabilities FY 2025 · Dec 31, 2024 $3.24M
Total Liabilities FY 2025 · Dec 31, 2025 $4.96M
Total Liabilities FY 2025 · Dec 31, 2024 $3.39M
Current Assets FY 2025 · Dec 31, 2025 $134.22M
Current Assets FY 2025 · Dec 31, 2024 $10.49M
Total Assets FY 2025 · Dec 31, 2025 $134.34M
Total Assets FY 2025 · Dec 31, 2024 $10.88M
Eps Diluted FY 2025 · Dec 31, 2025 −$0.30
Eps Diluted FY 2025 · Dec 31, 2024 −$10.19
Eps Basic FY 2025 · Dec 31, 2025 −$0.30
Eps Basic FY 2025 · Dec 31, 2024 −$10.19
Net Income FY 2025 · Dec 31, 2025 −$16.78M
Net Income FY 2025 · Dec 31, 2024 −$14.44M
Operating Income FY 2025 · Dec 31, 2025 −$18.06M
Operating Income FY 2025 · Dec 31, 2024 −$14.86M
Rd Expense FY 2025 · Dec 31, 2024 $16M